pharmabiz.com Unethical practice of dispensing cheap substitutes of low molecular weight heparin to patients, suffering from cardiac arrest, is found to be flourishing in several parts of India. These products are being sold at four times the actual cost by evading ...
Medscape WASHINGTON, DC — More than five months after the HEAT-PPCI STEMI trial of heparin monotherapy vs bivalirudin burst onto the radar of interventional cardiologists, the two men at opposite ends of this controversy took to the public stage to debate the ...
FiercePharma Manufacturing The FDA has kept a close eye on Chinese heparin makers ever since tainted crude heparin from China was tied to the deaths of dozens of dialysis patients in the U.S. The agency has now taken steps against a Chinese heparin maker it says is using ...
Regulatory Focus A Chinese-based manufacturer of heparin products has been sent a Warning Letter by the US Food and Drug Administration (FDA) after regulators accused the company of preventing FDA inspectors from accessing the facility earlier this year, and possibly ...
Anesthesiology News “Currently, there is insufficient data regarding the risk of neuraxial hematoma for analgesia in conjunction with heparin administered three times daily,” noted Jackson Su, MD, assistant professor of anesthesiology and perioperative medicine at the ...
PR Newswire (press release) ReportsnReports.com adds China Heparin Industry Report, 2014-2017 market research to its store that says in terms of the proposed/ongoing p...
